In Ah Kim

Nov 6, 2024 | mdpi.com | Sang Lee |Ngoc Nguyen |Inhee Jung |In Ah Kim

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Oct 3, 2023 | redjournal.org | Jin Kim |In Ah Kim |Integrated Major

1. McLane LM, Abdel-Hakeem MS, Wherry EJ. CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer. Annu. Rev. Immunol. 2019;37:457–495. 2. Philip M, Schietinger A. CD8+ T cell differentiation and dysfunction in cancer. Nat. Rev. Immunol. 2022;22:209–223. 3. Blackburn SD, Shin H, Freeman GJ, et al. Selective expansion of a subset of exhausted CD8 T cells by PD-L1 blockade. Proc. Natl. Acad. Sci. 2008;105:15016–15021. 4. Yost KE, Satpathy AT, Wells DK, et al.

Aug 22, 2023 | mdpi.com | SeongMin Kim |Seung Hyuck Jeon |In Ah Kim |Seung Hyuck

1. IntroductionRadiation therapy (RT) is one of the major pillars of cancer therapy and is used to treat a substantial portion of cancers [1], including breast cancer [2]. However, tumors often do not respond to RT or recur after RT [3]; thus, strategies to enhance the antitumor efficacy of RT need to be developed. To date, various systemic therapies have been investigated in clinical trials and preclinical models to improve the efficacy of local RT alone [4].